Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Caribou Biosciences (CRBU) Asset Utilization Ratio (2021 - 2025)

Historic Asset Utilization Ratio for Caribou Biosciences (CRBU) over the last 5 years, with Q3 2025 value amounting to 0.04.

  • Caribou Biosciences' Asset Utilization Ratio rose 3970.28% to 0.04 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.04, marking a year-over-year increase of 3970.28%. This contributed to the annual value of 0.03 for FY2024, which is 6866.21% down from last year.
  • Caribou Biosciences' Asset Utilization Ratio amounted to 0.04 in Q3 2025, which was up 3970.28% from 0.04 recorded in Q2 2025.
  • Over the past 5 years, Caribou Biosciences' Asset Utilization Ratio peaked at 0.09 during Q3 2023, and registered a low of 0.02 during Q4 2021.
  • Over the past 5 years, Caribou Biosciences' median Asset Utilization Ratio value was 0.04 (recorded in 2022), while the average stood at 0.04.
  • As far as peak fluctuations go, Caribou Biosciences' Asset Utilization Ratio soared by 17653.23% in 2023, and later plummeted by 6269.06% in 2024.
  • Quarter analysis of 5 years shows Caribou Biosciences' Asset Utilization Ratio stood at 0.02 in 2021, then surged by 68.92% to 0.04 in 2022, then soared by 116.14% to 0.08 in 2023, then tumbled by 60.78% to 0.03 in 2024, then skyrocketed by 47.07% to 0.04 in 2025.
  • Its Asset Utilization Ratio stands at 0.04 for Q3 2025, versus 0.04 for Q2 2025 and 0.03 for Q1 2025.